GS-5885, GS-9451, Tegobuvir and Ribavirin (RBV) in Interferon Ineligible or Intolerant Subjects With Chronic Genotype 1a or 1b Hepatitis C Virus (HCV) Infection
Clinical trial NCT01434498 · COMPLETED
Trial details
- NCT number
- NCT01434498
- Sponsor
- Gilead Sciences
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2011-09-01
- Primary completion
- 2013-01-01
- Enrollment
- 163
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.